Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

ASTRAZENECA PHARMA vs NEULAND LABS - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    ASTRAZENECA PHARMA NEULAND LABS ASTRAZENECA PHARMA/
NEULAND LABS
 
P/E (TTM) x 89.9 26.7 336.5% View Chart
P/BV x 16.2 2.6 615.2% View Chart
Dividend Yield % 0.3 0.3 104.5%  

Financials

 ASTRAZENECA PHARMA   NEULAND LABS
EQUITY SHARE DATA
    ASTRAZENECA PHARMA
Mar-22
NEULAND LABS
Mar-22
ASTRAZENECA PHARMA/
NEULAND LABS
5-Yr Chart
Click to enlarge
High Rs4,5802,840 161.3%   
Low Rs2,5291,000 252.9%   
Sales per share (Unadj.) Rs322.2741.3 43.5%  
Earnings per share (Unadj.) Rs24.649.7 49.5%  
Cash flow per share (Unadj.) Rs31.488.0 35.7%  
Dividends per share (Unadj.) Rs10.005.00 200.0%  
Avg Dividend yield %0.30.3 108.0%  
Book value per share (Unadj.) Rs203.8655.1 31.1%  
Shares outstanding (eoy) m25.0012.83 194.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x11.02.6 425.9%   
Avg P/E ratio x144.338.6 373.8%  
P/CF ratio (eoy) x113.121.8 518.3%  
Price / Book Value ratio x17.42.9 595.2%  
Dividend payout %40.610.1 403.8%   
Avg Mkt Cap Rs m88,86324,633 360.7%   
No. of employees `000NANA-   
Total wages/salary Rs m2,3021,825 126.2%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m8,0569,511 84.7%  
Other income Rs m14821 710.6%   
Total revenues Rs m8,2049,532 86.1%   
Gross profit Rs m8621,426 60.4%  
Depreciation Rs m170490 34.6%   
Interest Rs m10135 7.0%   
Profit before tax Rs m830822 101.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m214183 116.9%   
Profit after tax Rs m616638 96.5%  
Gross profit margin %10.715.0 71.3%  
Effective tax rate %25.822.3 115.7%   
Net profit margin %7.66.7 113.9%  
BALANCE SHEET DATA
Current assets Rs m7,6535,828 131.3%   
Current liabilities Rs m3,9233,632 108.0%   
Net working cap to sales %46.323.1 200.5%  
Current ratio x2.01.6 121.6%  
Inventory Days Days6114 444.6%  
Debtors Days Days39899 4.3%  
Net fixed assets Rs m2,1208,007 26.5%   
Share capital Rs m50129 38.8%   
"Free" reserves Rs m5,0448,276 61.0%   
Net worth Rs m5,0948,405 60.6%   
Long term debt Rs m01,042 0.0%   
Total assets Rs m9,77313,835 70.6%  
Interest coverage x88.47.1 1,247.3%   
Debt to equity ratio x00.1 0.0%  
Sales to assets ratio x0.80.7 119.9%   
Return on assets %6.45.6 114.5%  
Return on equity %12.17.6 159.2%  
Return on capital %16.510.1 162.8%  
Exports to sales %072.1 0.0%   
Imports to sales %31.717.0 186.8%   
Exports (fob) Rs mNA6,858 0.0%   
Imports (cif) Rs m2,5521,613 158.2%   
Fx inflow Rs m4426,858 6.4%   
Fx outflow Rs m2,5521,613 158.2%   
Net fx Rs m-2,1105,245 -40.2%   
CASH FLOW
From Operations Rs m1,008586 172.1%  
From Investments Rs m47-937 -5.1%  
From Financial Activity Rs m-95377 -25.1%  
Net Cashflow Rs m96127 3,617.5%  

Share Holding

Indian Promoters % 0.0 36.2 -  
Foreign collaborators % 75.0 0.0 -  
Indian inst/Mut Fund % 3.8 24.7 15.4%  
FIIs % 2.5 17.7 14.1%  
ADR/GDR % 0.0 0.0 -  
Free float % 25.0 63.8 39.2%  
Shareholders   49,085 30,600 160.4%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare ASTRAZENECA PHARMA With:   SUN PHARMA    DR. REDDYS LAB    CIPLA    LUPIN    AUROBINDO PHARMA    


More on ASTRAZENECA PHARMA vs NEULAND LABS

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

ASTRAZENECA PHARMA vs NEULAND LABS Share Price Performance

Period ASTRAZENECA PHARMA NEULAND LABS S&P BSE HEALTHCARE
1-Day -0.49% -0.37% -0.44%
1-Month -2.74% 17.68% -2.33%
1-Year 6.65% -4.64% -5.94%
3-Year CAGR 5.56% 57.20% 20.82%
5-Year CAGR 24.40% 13.65% 11.40%

* Compound Annual Growth Rate

Here are more details on the ASTRAZENECA PHARMA share price and the NEULAND LABS share price.

Moving on to shareholding structures...

The promoters of ASTRAZENECA PHARMA hold a 75.0% stake in the company. In case of NEULAND LABS the stake stands at 36.2%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of ASTRAZENECA PHARMA and the shareholding pattern of NEULAND LABS.

Finally, a word on dividends...

In the most recent financial year, ASTRAZENECA PHARMA paid a dividend of Rs 10.0 per share. This amounted to a Dividend Payout ratio of 40.6%.

NEULAND LABS paid Rs 5.0, and its dividend payout ratio stood at 10.1%.

You may visit here to review the dividend history of ASTRAZENECA PHARMA, and the dividend history of NEULAND LABS.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Tanks 320 Points| PolicyBazaar Stake Sale| Oil & Gas and Auto Stocks Witness Most Selling(10:30 am)

Indian share markets opened on a negative note today halting their eight-day rally, amid a weak trend in global markets.